Initial presentation of prostate cancer may hint different clinical characteristics along with serving predictive biomarker in castration-resistant prostate cancer patients treated with abiraterone acetate

dc.contributor.authorKose, F.
dc.contributor.authorSedef, A.
dc.contributor.authorBesen, A.
dc.contributor.authorMertsoylu, H.
dc.date.accessioned2020-11-02T16:06:48Z
dc.date.available2020-11-02T16:06:48Z
dc.date.issued2019
dc.description.sponsorship10th Eurasian Hematology Oncology Congressen_US
dc.identifier.endpageS35en_US
dc.identifier.issn0145-2126en_US
dc.identifier.startpageS34en_US
dc.identifier.urihttp://hdl.handle.net/11727/4990
dc.identifier.volume85en_US
dc.identifier.wos000489290100042en_US
dc.language.isoengen_US
dc.relation.journalLEUKEMIA RESEARCHen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleInitial presentation of prostate cancer may hint different clinical characteristics along with serving predictive biomarker in castration-resistant prostate cancer patients treated with abiraterone acetateen_US
dc.typeconferenceObjecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: